U.S. Physical Therapy Stock Price and Value Analysis

Should you buy U.S. Physical Therapy stock? (NYSE:USPH). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company has an average dividend yield.
  • This company has stable growth.
  • This company is solid.
  • This stock looks overpriced.
  • This company is making money at a modest rate.

Inside the USPH Numbers

USPH Price
(U.S. Physical Therapy stock price per share)
$86.17
[?] USPH Fair Price
(based on intrinsic value)
$39.50
[?] USPH Safety Price (based on a variable margin of safety) $25.68
[?] PE Ratio versus Sector 71% higher than other Healthcare stocks
[?] PE Ratio versus Industry 169% higher than other Unknown stocks
[?] Cash Yield 3.85%
[?] Free Cash Flow Jitter 21%
[?] Dividend Yield 2%
Shares Shorted 660,493

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 660,493 shares shorted. With 12,737,918 shares available for purchase and an average trading volume over the past 10 trading days of 89,040, it would take at least 7.418 days for all of the short holders to cover their shorts.

Is U.S. Physical Therapy Stock on Sale?

We believe that U.S. Physical Therapy may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

U.S. Physical Therapy looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy USPH Stock?

Does U.S. Physical Therapy have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.